BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32263769)

  • 1. Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer.
    Shahdordizadeh M; Yazdian-Robati R; Ramezani M; Abnous K; Taghdisi SM
    J Mater Chem B; 2016 Dec; 4(48):7766-7778. PubMed ID: 32263769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of aptamers in treatment and diagnosis of leukemia.
    Yazdian-Robati R; Arab A; Ramezani M; Abnous K; Taghdisi SM
    Int J Pharm; 2017 Aug; 529(1-2):44-54. PubMed ID: 28648578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamers in hematological malignancies and their potential therapeutic implications.
    Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
    Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy.
    Han J; Gao L; Wang J; Wang J
    J Cancer; 2020; 11(23):6902-6915. PubMed ID: 33123281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Highlight of Recent Advances in Aptamer Technology and Its Application.
    Sun H; Zu Y
    Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltammetric aptasensors for protein disease biomarkers detection: A review.
    Meirinho SG; Dias LG; Peres AM; Rodrigues LR
    Biotechnol Adv; 2016; 34(5):941-953. PubMed ID: 27235188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid aptamers in diagnosis of colorectal cancer.
    Ahmadyousefi Y; Malih S; Mirzaee Y; Saidijam M
    Biochimie; 2019 Jan; 156():1-11. PubMed ID: 30244135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the role of aptamers in the fight against cancer.
    Maimaitiyiming Y; Hong F; Yang C; Naranmandura H
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):797-810. PubMed ID: 30830295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the Study of Aptamer-Protein Target Identification Using the Chromatographic Approach.
    Drabik A; Ner-Kluza J; Mielczarek P; Civit L; Mayer G; Silberring J
    J Proteome Res; 2018 Jun; 17(6):2174-2181. PubMed ID: 29703078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-based nanobiosensors.
    Kim YS; Raston NH; Gu MB
    Biosens Bioelectron; 2016 Feb; 76():2-19. PubMed ID: 26139320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of food matrices on aptamer selection by SELEX (systematic evolution of ligands by exponential enrichment) targeting the norovirus P-Domain.
    Schilling KB; DeGrasse J; Woods JW
    Food Chem; 2018 Aug; 258():129-136. PubMed ID: 29655714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progresses in biomedical applications of aptamer-functionalized systems.
    Ding F; Gao Y; He X
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4256-4269. PubMed ID: 28803753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
    Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
    Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamers: selection, modification and application to nervous system diseases.
    Yang Y; Ren X; Schluesener HJ; Zhang Z
    Curr Med Chem; 2011; 18(27):4159-68. PubMed ID: 21838689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases.
    Xu Y; Jiang X; Zhou Y; Ma M; Wang M; Ying B
    Front Bioeng Biotechnol; 2021; 9():704077. PubMed ID: 34447741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in aptamer screening and small molecule aptasensors.
    Kim YS; Gu MB
    Adv Biochem Eng Biotechnol; 2014; 140():29-67. PubMed ID: 23851587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.